HIV-1 immunopathogenesis: How good interferon turns bad

Brenchley, 2004, CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract, J. Exp. Med., 200, 749, 10.1084/jem.20040874 Mehandru, 2004, Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract, J. Exp. Med., 200, 761, 10.1084/jem.20041196 Li, 2005, Peak SIV replication in resting memory CD4+T cells depletes gut lamina propria CD4+ T cells, Nature, 434, 1148, 10.1038/nature03513 Mattapallil, 2005, Massive infection and loss of memory CD4+T cells in multiple tissues during acute SIV infection, Nature, 434, 1093, 10.1038/nature03501 Levy, 1993, Pathogenesis of human immunodeficiency virus infection, Microbiol. Rev., 57, 183, 10.1128/MMBR.57.1.183-289.1993 Groux, 1992, Activation-induced death by apoptosis in CD4+T cells from human immunodeficiency virus-infected asymptomatic individuals, J. Exp. Med., 175, 331, 10.1084/jem.175.2.331 Schnittman, 1989, The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4, Science, 245, 305, 10.1126/science.2665081 Giorgi, 1993, Elevated levels of CD38+CD8+T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study, J. Acquired Immune Defic. Syndr., 6, 904 Isaacs, 1957, Virus interference: I. The interferon, Proc. R. Soc. London, Ser. B Biol. Sci. Biol. Sci., 147, 258, 10.1098/rspb.1957.0048 Bekisz, 2004, Human interferons alpha, beta and omega, Growth Factors, 22, 243, 10.1080/08977190400000833 Pitha, 1994, Multiple effects of interferon on the replication of human immunodeficiency virus type 1, Antiviral Res., 24, 205, 10.1016/0166-3542(94)90068-X Yamamoto, 1986, Human alpha- and beta-interferon but not gamma-suppress the in vitro replication of LAV, HTLV-III, and ARV-2, J. Interferon. Res., 6, 143, 10.1089/jir.1986.6.143 Fernandez-Cruz, 1995, Zidovudine plus interferon-alpha versus zidovudine alone in HIV-infected symptomatic or asymptomatic persons with CD4+ cell counts>150×10(6)/L: results of the Zidon trial. Zidon Study Group, AIDS, 9, 1025, 10.1097/00002030-199509000-00007 Lane, 1990, Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial, Ann. Intern. Med., 112, 805, 10.7326/0003-4819-112-11-805 Rivero, 1994, Use of recombinant interferon-alpha in human immunodeficiency virus (HIV)-infected individuals, Biotherapy, 8, 23, 10.1007/BF01878118 Skillman, 1996, Phase I trial of interferon alfa-n3 in early-stage human immunodeficiency virus type 1 disease: evidence for drug safety, tolerance, and antiviral activity, J. Infect. Dis., 173, 1107, 10.1093/infdis/173.5.1107 Krown, 2002, Efficacy of low-dose interferon with antiretroviral therapy in Kaposi's sarcoma: a randomized phase II AIDS clinical trials group study, J. Interferon. Cytokine Res., 22, 295, 10.1089/107999002753675712 Krown, 2006, Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial, J. Acquired Immune Defic. Syndr., 41, 149, 10.1097/01.qai.0000194237.15831.23 Bosinger, 2004, Gene expression profiling of host response in models of acute HIV infection, J. Immunol., 173, 6858, 10.4049/jimmunol.173.11.6858 Khatissian, 1996, The relationship between the interferon alpha response and viral burden in primary SIV infection, AIDS Res. Hum. Retroviruses, 12, 1273, 10.1089/aid.1996.12.1273 Zagury, 1998, Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C–C chemokine decline in AIDS, Proc. Natl. Acad. Sci. U. S. A., 95, 3851, 10.1073/pnas.95.7.3851 Gringeri, 1999, Active anti-interferon-alpha immunization: a European–Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study), J. Acquired Immune Defic. Syndr. Hum. Retrovirol., 20, 358, 10.1097/00042560-199904010-00006 Francis, 1993, Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication, J. Immunol., 151, 2208 Siegal, 1999, The nature of the principal type 1 interferon-producing cells in human blood, Science, 284, 1835, 10.1126/science.284.5421.1835 Colonna, 2004, Plasmacytoid dendritic cells in immunity, Nat. Immunol., 5, 1219, 10.1038/ni1141 Siegal, 1986, Opportunistic infections in acquired immune deficiency syndrome result from synergistic defects of both the natural and adaptive components of cellular immunity, J. Clin. Invest, 78, 115, 10.1172/JCI112539 Siegal, 2001, Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection, AIDS, 15, 1603, 10.1097/00002030-200109070-00002 Donaghy, 2001, Loss of blood CD11c(+) myeloid and CD11c(−) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load, Blood, 98, 2574, 10.1182/blood.V98.8.2574 Soumelis, 2001, Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients, Blood, 98, 906, 10.1182/blood.V98.4.906 Lichtner, 2006, Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response, Clin. Exp. Immunol., 143, 329, 10.1111/j.1365-2249.2005.02994.x Fonteneau, 2004, Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells, J. Virol., 78, 5223, 10.1128/JVI.78.10.5223-5232.2004 Herbeuval, 2005, Regulation of TNF-related apoptosis-inducing ligand on primary CD4+T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells, Proc. Natl. Acad. Sci. U S. A., 102, 13974, 10.1073/pnas.0505251102 Schmidt, 2005, HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration, Virology, 343, 256, 10.1016/j.virol.2005.09.059 Yonezawa, 2003, Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells, J. Virol., 77, 3777, 10.1128/JVI.77.6.3777-3784.2003 Herbeuval, 2006, Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients, Proc. Natl. Acad. Sci. U. S. A., 103, 7000, 10.1073/pnas.0600363103 Badley, 2000, Mechanisms of HIV-associated lymphocyte apoptosis, Blood, 96, 2951, 10.1182/blood.V96.9.2951 Petit, 2001, Role of CD95-activated caspase-1 processing of IL-1beta in TCR-mediated proliferation of HIV-infected CD4(+) T cells, Eur. J. Immunol., 31, 3513, 10.1002/1521-4141(200112)31:12<3513::AID-IMMU3513>3.0.CO;2-J Esser, 2001, Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1, J. Virol., 75, 1152, 10.1128/JVI.75.3.1152-1164.2001 Gandhi, 1998, HIV-1 directly kills CD4+T cells by a Fas-independent mechanism, J. Exp. Med., 187, 1113, 10.1084/jem.187.7.1113 Kayagaki, 1999, Involvement of TNF-related apoptosis-inducing ligand in human CD4+T cell-mediated cytotoxicity, J. Immunol., 162, 2639 Vidalain, 2001, Measle virus-infected dendritic cells develop immunosuppressive and cytotoxic activities, Immunobiology, 204, 629, 10.1078/0171-2985-00102 Herbeuval, 2003, Macrophages from cancer patients: analysis of TRAIL, TRAIL Receptors, and colon tumor cell apoptosis, J. Natl. Cancer Inst., 95, 611, 10.1093/jnci/95.8.611 Sheridan, 1997, Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors, Science, 277, 818, 10.1126/science.277.5327.818 Chaudhary, 1997, Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway, Immunity, 7, 821, 10.1016/S1074-7613(00)80400-8 Hansjee, 2004, Persistent apoptosis in HIV-1-infected individuals receiving potent antiretroviral therapy is associated with poor recovery of CD4 T lymphocytes, J. Acquired Immune Defic. Syndr., 36, 671, 10.1097/00126334-200406010-00003 Lichtner, 2004, HIV type 1-infected dendritic cells induce apoptotic death in infected and uninfected primary CD4 T lymphocytes, AIDS Res. Hum. Retroviruses, 20, 175, 10.1089/088922204773004897 Katsikis, 1997, Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection, J. Exp. Med., 186, 1365, 10.1084/jem.186.8.1365 Lum, 2001, Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l, J. Virol., 75, 11128, 10.1128/JVI.75.22.11128-11136.2001 Miura, 2001, Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4(+) T cells in HIV-1-infected hu-PBL-NOD-SCID mice, J. Exp. Med., 193, 651, 10.1084/jem.193.5.651 Yang, 2003, Monocytes treated with human immunodeficiency virus tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism, J. Virol., 77, 6700, 10.1128/JVI.77.12.6700-6708.2003 Miura, 2003, TNF-related apoptosis-inducing ligand (TRAIL) induces neuronal apoptosis in HIV-encephalopathy, J. Med. Dent. Sci., 50, 17 Ryan, 2004, TNF-related apoptosis-inducing ligand mediates human neuronal apoptosis: links to HIV-1-associated dementia, J. Neuroimmunol., 148, 127, 10.1016/j.jneuroim.2003.11.019 Herbeuval, 2005, TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells, Blood, 105, 2458, 10.1182/blood-2004-08-3058 Herbeuval, 2005, CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis, Blood, 106, 3524, 10.1182/blood-2005-03-1243 Dimitrov, 1993, Quantitation of human immunodeficiency virus type 1 infection kinetics, J. Virol., 67, 2182, 10.1128/JVI.67.4.2182-2190.1993 Piatak, 1993, High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR, Science, 259, 1749, 10.1126/science.8096089 Finkel, 1995, Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes, Nat. Med., 1, 129, 10.1038/nm0295-129 Rossio, 1998, Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins, J. Virol., 72, 7992, 10.1128/JVI.72.10.7992-8001.1998 Takaoka, 2003, Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence, Nature, 424, 516, 10.1038/nature01850 Vilcek, 2003, Boosting p53 with interferon and viruses, Nat. Immunol., 4, 825, 10.1038/ni0903-825 Beignon, 2005, Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions, J. Clin. Invest., 10.1172/JCI26032 Kaser, 1999, Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression, Cytokine, 11, 736, 10.1006/cyto.1998.0484 Dondi, 2004, A dual role of IFN-alpha in the balance between proliferation and death of human CD4+ T lymphocytes during primary response, J. Immunol., 173, 3740, 10.4049/jimmunol.173.6.3740 Herbeuval, 2006, Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?, AIDS Rev., 8, 3 Jacobson, 2004, Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542, Antimicrob. Agents Chemother., 48, 423, 10.1128/AAC.48.2.423-429.2004 Martin, 2003, Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes, Nat. Biotechnol., 21, 71, 10.1038/nbt768 Finkel, 1994, Indirect mechanisms of HIV pathogenesis: how does HIV kill T cells?, Curr. Opin. Immunol., 6, 605, 10.1016/0952-7915(94)90149-X